• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·PANCHSHEEL.BO
Share

Panchsheel Organics Limited Stocks

₹ 104Last Updated 19.10.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 14.70M

₹ 104
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Founded on August 2, 1989, Panchsheel Organics Ltd. is an Indian enterprise based in Mumbai, specializing in the production of pharmaceutical and medicinal chemical goods. The company's diverse offerings include anti-cancer medications (spanning oncology and therapeutics), biosimilar products, nutraceuticals, and a variety of fitness and wellness items. Additionally, it provides steroids and hormones, veterinary medicines, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs) with their intermediates, supported by its dedicated development and testing laboratory.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 20:11

"A Vicious Cycle": What Risks Does Rising Bond Yields Pose to the Stock Market?

20.10.2026 19:39

"The Weak Link": The risk premium on French government bonds has approached a 15-year high

20.10.2026 19:05

The success of the hair loss pill trials has boosted the developer's stock price. Should you buy them?

20.10.2026 18:41

Digital Twins: Why Kazakhstan Is Implementing Artificial Intelligence in Industry

20.10.2026 18:18

General Motors announced a $20 billion buyback. Why did its stock price fall?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026